Pulmonx (LUNG) Current Assets (2019 - 2025)

Pulmonx (LUNG) has 7 years of Current Assets data on file, last reported at $101.7 million in Q4 2025.

• On a quarterly basis, Current Assets fell 25.37% year-over-year to $101.7 million in Q4 2025; TTM through Dec 2025 was $101.7 million, a 25.37% decrease from a year earlier, with the FY2025 full-year figure at $101.7 million, down 25.37% from the prior year.
• Current Assets for Q4 2025 stood at $101.7 million, down from $111.2 million in the prior quarter.
• Over the last five years, Current Assets for LUNG reached as high as $239.3 million in Q1 2021 and fell as low as $101.7 million in Q4 2025.
• Historically, Current Assets has averaged $166.3 million across 5 years, with a median of $157.4 million in 2023.
• Across the five-year window, Current Assets soared 309.27% in 2021 and slipped 25.37% in 2025, its largest moves.
• Year by year, Current Assets stood at $208.0 million in 2021, then dropped by 18.77% to $169.0 million in 2022, then fell by 10.97% to $150.4 million in 2023, then retreated by 9.42% to $136.2 million in 2024, then decreased by 25.37% to $101.7 million in 2025.
• Per Business Quant data, the three most recent Current Assets figures were $101.7 million in Q4 2025, $111.2 million in Q3 2025, and $120.0 million in Q2 2025.